Healthcare provider profile · identity verified

Matthew Abbate, MD

Internal Medicine · NASHVILLE, TN · NPI 1982796306

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	721	207
Lisinopril	Lisinopril	383	109
Amlodipine Besylate	Amlodipine Besylate	377	101
Levothyroxine Sodium	Levothyroxine Sodium	370	96
Losartan Potassium	Losartan Potassium	303	84
Gabapentin	Gabapentin	295	83
Pantoprazole Sodium	Pantoprazole Sodium	290	86
Metoprolol Succinate	Metoprolol Succinate	216	58
Rosuvastatin Calcium	Rosuvastatin Calcium	208	63
Omeprazole	Omeprazole	206	64
Hydrochlorothiazide	Hydrochlorothiazide	188	59
Sertraline Hcl	Sertraline Hcl	184	43
Glipizide Er	Glipizide	163	38
Tamsulosin Hcl	Tamsulosin Hcl	156	42
Metformin Hcl Er	Metformin Hcl	155	46
Simvastatin	Simvastatin	149	40
Fluticasone Propionate	Fluticasone Propionate	142	56
Duloxetine Hcl	Duloxetine Hcl	138	39
Alprazolam	Alprazolam	134	23
Metformin Hcl	Metformin Hcl	127	35
Montelukast Sodium	Montelukast Sodium	126	31
Pravastatin Sodium	Pravastatin Sodium	125	38
Trazodone Hcl	Trazodone Hcl	119	34
Zolpidem Tartrate	Zolpidem Tartrate	118	34
Metoprolol Tartrate	Metoprolol Tartrate	116	32
Allopurinol	Allopurinol	115	32
Carvedilol	Carvedilol	112	33
Ezetimibe	Ezetimibe	112	30
Buspirone Hcl	Buspirone Hcl	110	30
Escitalopram Oxalate	Escitalopram Oxalate	101	27
Eliquis	Apixaban	100	26
Ozempic	Semaglutide	98	21
Furosemide	Furosemide	95	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	94	24
Trulicity	Dulaglutide	89	13
Lansoprazole	Lansoprazole	85	22
Albuterol Sulfate Hfa	Albuterol Sulfate	80	38
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	75	20
Azelastine Hcl	Azelastine Hcl	68	27
Finasteride	Finasteride	68	21
Fluoxetine Hcl	Fluoxetine Hcl	67	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	66	18
Tramadol Hcl	Tramadol Hcl	65	16
Synthroid	Levothyroxine Sodium	62	17
Jardiance	Empagliflozin	61	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	55	12
Valsartan	Valsartan	53	13
Benazepril Hcl	Benazepril Hcl	52	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	14
Prednisone	Prednisone	49	30
Clopidogrel	Clopidogrel Bisulfate	48	15
Clonazepam	Clonazepam	47	suppressed
Diazepam	Diazepam	47	suppressed
Famotidine	Famotidine	45	13
Lorazepam	Lorazepam	45	11
Potassium Chloride	Potassium Chloride	45	18
Amitriptyline Hcl	Amitriptyline Hcl	40	suppressed
Bupropion Xl	Bupropion Hcl	40	14
Celecoxib	Celecoxib	39	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	39	14
Promethazine Hcl	Promethazine Hcl	39	suppressed
Spironolactone	Spironolactone	39	suppressed
Ramipril	Ramipril	37	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	36	suppressed
Meloxicam	Meloxicam	36	13
Mounjaro	Tirzepatide	36	suppressed
Glimepiride	Glimepiride	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	13
Warfarin Sodium	Warfarin Sodium	33	11
Chlorthalidone	Chlorthalidone	32	suppressed
Atenolol	Atenolol	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	12
Telmisartan	Telmisartan	30	suppressed
Valacyclovir	Valacyclovir Hcl	28	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	11
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Baclofen	Baclofen	24	suppressed
Fenofibrate	Fenofibrate,micronized	24	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Repatha Sureclick	Evolocumab	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	16
Glipizide	Glipizide	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	19
Eszopiclone	Eszopiclone	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Risedronate Sodium	Risedronate Sodium	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Doxepin Hcl	Doxepin Hcl	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Klor-Con M20	Potassium Chloride	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	15
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Ondansetron Odt	Ondansetron	14	11
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Estradiol	Estradiol	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Praluent Pen	Alirocumab	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Testosterone	Testosterone	13	suppressed
Torsemide	Torsemide	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Temazepam	Temazepam	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error